{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:10:16Z","timestamp":1793999416250,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2016YFA0100900"],"award-info":[{"award-number":["2016YFA0100900"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871403"],"award-info":[{"award-number":["81871403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Research and Development Program of Zhejiang Province","award":["2019C03014, 2017C03042"],"award-info":[{"award-number":["2019C03014, 2017C03042"]}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"crossref","award":["2018KY396"],"award-info":[{"award-number":["2018KY396"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902720"],"award-info":[{"award-number":["81902720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Health Science and Technology Project of Zhejiang Province of china","award":["2020RC015"],"award-info":[{"award-number":["2020RC015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To develop a nanoparticle-based MRI protocol based on transrectal administration of intestine-absorbable nanoparticle contrast agents to evaluate ulcerative colitis (UC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Solid lipid nanoparticles (SLNs) were synthesized by loading gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) and octadecylamine-fluorescein isothiocyanate to produce Gd-FITC-SLNs as T1 contrast agents. Twenty mice with acute UC were divided into four groups: enema with Gd-FITC-SLNs, intravenous injection of Gd-FITC-SLNs, enema with Gd-DTPA, and intravenous injection of Gd-DTPA. Five mice with chronic UC and five mice without UC underwent enema with Gd-FITC-SLNs. Axial T1- and T2-weighted MR images were obtained before and 20, 40, 60, 80,100, and 120 min after enema or intravenous injection of the contrast agent. The signal-to-noise ratios (SNRs) of the colorectal wall were measured in both groups. The MRI findings were correlated with subsequent histological confirmation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At 20 min after enema with Gd-FITC-SLNs, MRI showed the following contrast enhancement pattern: acute UC &gt; normal intestinal wall &gt; chronic UC. A continuous enhancement effect was observed in mice with acute UC, whereas a slight continuous enhancement of the colorectal wall was observed in mice with chronic UC. The normal intestinal wall rapidly metabolized the contrast agent, and the enhancement decreased on sequential scans. There was no significant difference between the SNRs of the intestinal wall at 20 min after intravenous Gd-DTPA and transrectal Gd-FITC-SLN administration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC and can confer the same or better results than with intravenous Gd-DTPA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p>\u2022 <jats:italic>Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Enema with Gd-FITC-SLNs can achieve the same or better result than that with intravenous Gd-DTPA.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>SLN-based MR colonography enhances the colorectal wall inflammation, based on the colonic absorption of the nanoparticle contrast agents.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-020-07609-8","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T23:03:06Z","timestamp":1609974186000},"page":"4615-4624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation"],"prefix":"10.1007","volume":"31","author":[{"given":"Xue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"7609_CR1","doi-asserted-by":"publisher","unstructured":"Lo CH, Khalili H, Song M et al (2020) Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases [published online ahead of print, 2020 Mar 3]. Clin Gastroenterol Hepatol:S1542-3565(20)30266-4. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.047","DOI":"10.1016\/j.cgh.2020.02.047"},{"key":"7609_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019) ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol 114:384\u2013413","journal-title":"Am J Gastroenterol"},{"key":"7609_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3748\/wjg.v26.i8.877","volume":"26","author":"YW Chen","year":"2020","unstructured":"Chen YW, Tu JF, Shen WJ et al (2020) Diagnosis and management of a solitary colorectal juvenile polyp in an adult during follow-up for ulcerative colitis: a case report. World J Gastroenterol 26:877\u2013882","journal-title":"World J Gastroenterol"},{"key":"7609_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.dld.2012.09.005","volume":"45","author":"C Gower-Rousseau","year":"2013","unstructured":"Gower-Rousseau C, Vasseur F, Fumery M et al (2013) Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 45:89\u201394","journal-title":"Dig Liver Dis"},{"key":"7609_CR5","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1021\/bc300461r","volume":"23","author":"J Lim","year":"2012","unstructured":"Lim J, Turkbey B, Bernardo M et al (2012) Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. Bioconjug Chem 23:2291\u20132299","journal-title":"Bioconjug Chem"},{"key":"7609_CR6","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/cr980440x","volume":"99","author":"P Caravan","year":"1999","unstructured":"Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium (III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev 99:2293\u20132352","journal-title":"Chem Rev"},{"key":"7609_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20\u201337","journal-title":"Nat Rev Cancer"},{"key":"7609_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc1566","volume":"5","author":"M Ferrari","year":"2005","unstructured":"Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161\u2013171","journal-title":"Nat Rev Cancer"},{"key":"7609_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","volume":"23","author":"P Couvreur","year":"2006","unstructured":"Couvreur P, Vauthier C (2006) Nanotechnology: intelligent design to treat complex disease. Pharm Res 23:1417\u20131450","journal-title":"Pharm Res"},{"key":"7609_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejpb.2005.09.003","volume":"62","author":"N Pedersen","year":"2006","unstructured":"Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS (2006) Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 62:155\u2013162","journal-title":"Eur J Pharm Biopharm"},{"key":"7609_CR11","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/anie.201311245","volume":"53","author":"M Wang","year":"2014","unstructured":"Wang M, Alberti K, Sun S, Arellano CL, Xu Q (2014) Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy. Angew Chem Int Ed Engl 53:2893\u20132898","journal-title":"Angew Chem Int Ed Engl"},{"key":"7609_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ics.12452","volume":"40","author":"V Saez","year":"2018","unstructured":"Saez V, Souza IDL, Mansur CRE (2018) Lipid nanoparticles (SLN & NLC) for delivery of vitamin E: a comprehensive review. Int J Cosmet Sci 40:103\u2013116","journal-title":"Int J Cosmet Sci"},{"key":"7609_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50:161\u2013177","journal-title":"Eur J Pharm Biopharm"},{"key":"7609_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijpharm.2016.11.026","volume":"516","author":"A F\u00e0bregas","year":"2017","unstructured":"F\u00e0bregas A, Prieto-S\u00e1nchez S, Su\u00f1\u00e9-Pou M et al (2017) Improved formulation of cationic solid lipid nanoparticles displays cellular uptake and biological activity of nucleic acids. Int J Pharm 516:39\u201344","journal-title":"Int J Pharm"},{"key":"7609_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0939-6411(97)00107-0","volume":"45","author":"S Morel","year":"1998","unstructured":"Morel S, Terreno E, Ugazio E, Aime S, Gasco MR (1998) NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexes. Eur J Pharm Biopharm 45:157\u2013163","journal-title":"Eur J Pharm Biopharm"},{"key":"7609_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.colsurfb.2007.07.015","volume":"61","author":"H Yuan","year":"2008","unstructured":"Yuan H, Huang LF, Du YZ et al (2008) Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces 61:132\u2013137","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7609_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mrm.22654","volume":"65","author":"J Sun","year":"2011","unstructured":"Sun J, Zheng W, Zhang H et al (2011) Development of nanoparticle-based magnetic resonance colonography. Magn Reson Med 65:673\u2013679","journal-title":"Magn Reson Med"},{"key":"7609_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpharm.2007.07.012","volume":"348","author":"H Yuan","year":"2008","unstructured":"Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S (2008) Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348:137\u2013145","journal-title":"Int J Pharm"},{"key":"7609_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5946\/ce.2013.46.4.327","volume":"46","author":"MJ Park","year":"2013","unstructured":"Park MJ, Lim JS (2013) Computed tomography enterography for evaluation of inflammatory bowel disease. Clin Endosc 46:327\u2013366","journal-title":"Clin Endosc"},{"key":"7609_CR20","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1007\/s00330-020-06684-1","volume":"30","author":"S Lee","year":"2020","unstructured":"Lee S, Choi YH, Cho YJ et al (2020) Quantitative evaluation of Crohn's disease using dynamic contrast-enhanced MRI in children and young adults. Eur Radiol 30:3168\u20133177","journal-title":"Eur Radiol"},{"key":"7609_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1651-2227.2012.02607.x","volume":"101","author":"M Piekkala","year":"2012","unstructured":"Piekkala M, Kalajoki-Helmi\u00f6 T, Martelius L, Pakarinen M, Rintala R, Kolho KL (2012) Magnetic resonance enterography guiding treatment in children with Crohn\u2019s jejunoileitis. Acta Paediatr 101:631\u2013636","journal-title":"Acta Paediatr"},{"key":"7609_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/gutjnl-2012-303240","volume":"62","author":"I Ordas","year":"2013","unstructured":"Ordas I, Rimola J, Garcia-Bosch O et al (2013) Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study. Gut 62:1566\u20131572","journal-title":"Gut"},{"key":"7609_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jmri.22504","volume":"33","author":"MS Gee","year":"2011","unstructured":"Gee MS, Harisinghani MG (2011) MRI in patients with inflammatory bowel disease. J Magn Reson Imaging 33:527\u2013534","journal-title":"J Magn Reson Imaging"},{"key":"7609_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/1522-2586(200008)12:2<205::AID-JMRI1>3.0.CO;2-P","volume":"12","author":"VM Runge","year":"2000","unstructured":"Runge VM (2000) Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 12:205\u2013213","journal-title":"J Magn Reson Imaging"},{"key":"7609_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00002142-199806000-00002","volume":"9","author":"RN Low","year":"1998","unstructured":"Low RN (1998) Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver. Top Magn Reson Imaging 9:141\u2013166","journal-title":"Top Magn Reson Imaging"},{"key":"7609_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2214\/ajr.142.3.619","volume":"142","author":"HJ Weinmann","year":"1984","unstructured":"Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 142:619\u2013624","journal-title":"AJR Am J Roentgenol"},{"key":"7609_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/RLI.0000000000000227","volume":"50","author":"A Radbruch","year":"2015","unstructured":"Radbruch A, Weberling LD, Kieslich PJ et al (2015) High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Invest Radiol 50:805\u2013810","journal-title":"Invest Radiol"},{"key":"7609_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.nano.2011.08.016","volume":"8","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Gao F, Bu H, Xiao J, Li Y (2012) Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine 8:740\u2013747","journal-title":"Nanomedicine"},{"key":"7609_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1057","volume":"3","author":"AM Mowat","year":"2003","unstructured":"Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3:331\u2013341","journal-title":"Nat Rev Immunol"},{"key":"7609_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biomaterials.2015.01.013","volume":"48","author":"Z Huang","year":"2015","unstructured":"Huang Z, Gan J, Jia L et al (2015) An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease. Biomaterials 48:26\u201336","journal-title":"Biomaterials"},{"key":"7609_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ecco-jcc\/jjx115","volume":"12","author":"M Zhang","year":"2018","unstructured":"Zhang M, Xu C, Liu D, Han MK, Wang L, Merlin D (2018) Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. J Crohns Colitis 12:217\u2013229","journal-title":"J Crohns Colitis"},{"key":"7609_CR32","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1166\/jbn.2016.2285","volume":"12","author":"J Sun","year":"2016","unstructured":"Sun J, Zhang S, Jiang S et al (2016) Gadolinium-loaded solid lipid nanoparticles as a tumor-absorbable contrast agent for early diagnosis of colorectal tumors using magnetic resonance colonography. J Biomed Nanotechnol 12:1709\u20131723","journal-title":"J Biomed Nanotechnol"},{"key":"7609_CR33","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3748\/wjg.v23.i11.1944","volume":"23","author":"T Iida","year":"2017","unstructured":"Iida T, Onodera K, Nakase H (2017) Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 23:1944\u20131953","journal-title":"World J Gastroenterol"},{"key":"7609_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MOP.0000000000000531","volume":"29","author":"JR Kelsen","year":"2017","unstructured":"Kelsen JR, Baldassano RN (2017) The role of monogenic disease in children with very early onset inflammatory bowel disease. Curr Opin Pediatr 29:566\u2013571","journal-title":"Curr Opin Pediatr"},{"key":"7609_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/0-387-33778-4_8","volume":"579","author":"F Leon","year":"2006","unstructured":"Leon F, Smythies LE, Smith PD, Kelsall BL (2006) Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease. Adv Exp Med Biol 579:117\u2013132","journal-title":"Adv Exp Med Biol"},{"key":"7609_CR36","unstructured":"(2005) Chronic inflammatory bowel diseases. Update on evidence based therapy. MMW Fortschr Med 147(17):58\u201359"},{"key":"7609_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427\u2013434","journal-title":"Nature"},{"key":"7609_CR38","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1039\/C6SC01011C","volume":"7","author":"L Qin","year":"2016","unstructured":"Qin L, Hartley A, Turner P, Elmes RBP, Jolliffe KA (2016) Macrocyclic squaramides: anion receptors with high sulfate binding affinity and selectivity in aqueous media. Chem Sci 7:4563\u20134572","journal-title":"Chem Sci"},{"key":"7609_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"GR D'Haens","year":"1998","unstructured":"D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P (1998) Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114:262\u2013267","journal-title":"Gastroenterology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-07609-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:11:21Z","timestamp":1624011081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-07609-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["7609"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-07609-8","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Xiujun Cai, Email: caixiujun@zju.edu.cn.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"The authors declare that there are no informed consents.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Animal experiments were conducted according to protocols approved by the Institutional Committee for Animal Care and housed according to institutional guidelines","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 prospective\/retrospective\u2022 case-control study\/cross-sectional study\/randomised controlled trial\/diagnostic or prognostic study\/observational\/experimental\u2022 multicenter study\/performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}